Dr. Ehimen Jude Okpoloa, MD

Dr. Okpoloa practices at Deaconess Midtown Hospital - Outpatient Therapy in Evansville, Indiana.

Dr. Okpoloa's NPI, 1689201733, was assigned on March 26, 2020. Dr. Okpoloa holds Rhode Island license LP05028.

Dr. Okpoloa's primary practice is Deaconess Midtown Hospital - Outpatient Therapy, at 600 Mary St, Evansville, IN 47747. The practice phone is (812) 450-3324.

Dr. Okpoloa's primary practice is Deaconess Midtown Hospital - Outpatient Therapy in Evansville, Indiana. Dr. Okpoloa is also affiliated with Deaconess Midtown Hospital. The medical group on file is Deaconess Health System. Dmand AI also links Dr. Okpoloa to 2 more hospitals, 6 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Okpoloa practices, 5 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Okpoloa's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dmand AI has Dr. Okpoloa's licenses on file in 3 states: Rhode Island, Indiana and Kentucky.

CMS data shows 686 Medicare services from Dr. Okpoloa across 7 procedure codes in 2024, for 557 Medicare patients. Medicare paid $74,675 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 557 Medicare patients who saw Dr. Okpoloa in 2024. The largest group is 65 to 74, with 187 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 27% are also on Medicaid. Their average risk score is 2.39, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Okpoloa's median patient age at 71, with 52% women.

In 2024, Dr. Okpoloa wrote 201 Medicare Part D claims for 84 patients. 87% of them were for generic drugs. CMS names the drug for 73 of them, across 6 drugs with 11 or more claims each, at $8,851 in total drug cost. In 2023, CMS named 106 claims across 7 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Okpoloa for performance year 2024, reported as part of a group. Dr. Okpoloa accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 6 general payments to Dr. Okpoloa from 4 drug and device companies from 2023 to 2025. Food and beverage make up the largest share, 100% of the total. Bausch Health Americas, Inc. paid the most, $49.